September 30, 2021

The SatioPatch™ Platform provides consumer-based diagnosis and eliminates the need for needles administered by a medical professional.

Technology that allows real-time, accurate detection of a wide range of specific targets, and delivers results within minutes.

MORE NEWS

September 9, 2022
Sapphiros has today completed the acquisition of Flexotronix Limited.
August 24, 2022
The partnership aims to enable low-cost access to vaccines and diagnostics to advance public health in Africa and beyond.
August 23, 2022
Satio and INTACT Solutions have entered into an agreement to establish a collaborative framework in order to partner on research, development, manufacture, and deployment of next generation health technologies with the goal of offering alternative solutions to traditional needles with SatioRx™ intradermal patches for the Member States of the African Union and beyond.